Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk (2015)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1097/HJH.0000000000000532
- Subjects: PRESSÃO SANGUÍNEA (CONTROLE); HIPERTENSÃO; HEPATOPATIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of hypertension
- ISSN: 0263-6352
- Volume/Número/Paginação/Ano: v. 33, p. 1207-1214, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ANENI, Ehimen C. et al. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. Journal of hypertension, v. 33, p. 1207-1214, 2015Tradução . . Disponível em: https://doi.org/10.1097/HJH.0000000000000532. Acesso em: 27 fev. 2026. -
APA
Aneni, E. C., Oni, E. T., Martin, S. S., Blaha, M. J., Agatston, A. S., Feldman, T., et al. (2015). Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. Journal of hypertension, 33, 1207-1214. doi:10.1097/HJH.0000000000000532 -
NLM
Aneni EC, Oni ET, Martin SS, Blaha MJ, Agatston AS, Feldman T, Veledar E, Conçeicao RD, Carvalho JAM, Santos RD, Nasir K. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk [Internet]. Journal of hypertension. 2015 ; 33 1207-1214.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1097/HJH.0000000000000532 -
Vancouver
Aneni EC, Oni ET, Martin SS, Blaha MJ, Agatston AS, Feldman T, Veledar E, Conçeicao RD, Carvalho JAM, Santos RD, Nasir K. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk [Internet]. Journal of hypertension. 2015 ; 33 1207-1214.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1097/HJH.0000000000000532 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1097/HJH.0000000000000532 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
